Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNotes PayablesOperating LeasesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Cannabis Suisse (CSUI) Common Equity (2016 - 2025)

Cannabis Suisse (CSUI) has disclosed Common Equity for 10 consecutive years, with -$1.8 million as the latest value for Q4 2025.

  • On a quarterly basis, Common Equity rose 5.87% to -$1.8 million in Q4 2025 year-over-year; TTM through Nov 2025 was -$1.8 million, a 5.87% increase, with the full-year FY2025 number at -$1.8 million, down 33.89% from a year prior.
  • Common Equity was -$1.8 million for Q4 2025 at Cannabis Suisse, up from -$1.8 million in the prior quarter.
  • In the past five years, Common Equity ranged from a high of -$187494.0 in Q2 2021 to a low of -$1.9 million in Q3 2024.
  • A 5-year average of -$837522.6 and a median of -$384204.0 in 2023 define the central range for Common Equity.
  • Peak YoY movement for Common Equity: surged 54.19% in 2021, then crashed 389.56% in 2024.
  • Cannabis Suisse's Common Equity stood at -$293634.0 in 2021, then rose by 22.99% to -$226129.0 in 2022, then crashed by 80.87% to -$409001.0 in 2023, then tumbled by 358.64% to -$1.9 million in 2024, then grew by 5.87% to -$1.8 million in 2025.
  • Per Business Quant, the three most recent readings for CSUI's Common Equity are -$1.8 million (Q4 2025), -$1.8 million (Q3 2025), and -$1.8 million (Q2 2025).